FIELD: immunology; paediatrics; pulmonology; nephrology.
SUBSTANCE: invention relates to medicine, namely to immunology, pediatrics, pulmonology, nephrology, can be used for immunomodulation in children aged 5–17 years with bronchial asthma and metabolic disorders in kidney diseases. To solve the problem, basic therapy is supplemented with the intake of the functional "DoroMarin" food product based on Far Eastern kelp, homogenized for 2 months according to the following scheme: for children weighing 20–50 kg — 10 ml 2 times a day in the morning 20–30 minutes before meals and in the evening 1.5–2 hours after meals; children weighing more than 50 kg — 15 ml 2 times a day in the morning 20–30 minutes before meals and in the evening 1.5–2 hours after meals.
EFFECT: improvement of the effectiveness of treatment and prevention of bronchial asthma and metabolic disorders in kidney diseases in children aged 5–17 years.
1 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
| METHOD OF DETERMINING PROINFLAMMATORY AND PROALLERGIC INTERLEUKINS IN NASAL SECRETION IN INFANTS AND PRESCHOOL CHILDREN FOR DIAGNOSTICS OF AETIOLOGY OF RECURRING ACUTE RHINOPHARYNGITIS AND ADENOIDITIS | 2013 |
|
RU2569054C2 |
| METHOD FOR DETERMINING DEGREE OF BRONCHIAL OBSTRUCTION IN PATIENTS WITH BRONCHIAL ASTHMA AND ACCOMPANYING OBESITY | 2019 |
|
RU2692229C1 |
| METHOD FOR IMMUNE CORRECTION IN PNEUMONIA | 2006 |
|
RU2305555C1 |
| METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA AND/OR CYSTIC FIBROSIS ACCOMPANYING INFLUENZA IN CHILDREN | 2013 |
|
RU2522276C1 |
| USING MOLECULAR MARKERS IL-3, IL-33 AND IL12Ρ40 TO CHARACTERIZE SEVERITY OF RESPIRATORY INFECTIONS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS | 2016 |
|
RU2707549C2 |
| METHOD OF ASSESSING THE QUALITY OF RECONVALESCENCE IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2018 |
|
RU2703705C1 |
| METHOD FOR PREVENTION OF EXACERBATION OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2625744C1 |
| METHOD OF ALLERGEN-SPECIFIC IMMUNOTHERAPY EFFICIENCY EVALUATION APPLIED FOR CHILDREN SUFFERING FROM BRONCHIAL ASTHMA | 2007 |
|
RU2327993C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF EPSHTEIN-BARR-VIRAL ETIOLOGY, ACUTE BACTERIAL TONSILLITIS AND ACUTE VIRAL HEPATITIS “B” IN ADULTS | 2017 |
|
RU2687563C2 |
